| |
|
|
|
Hemispherx Biopharma Inc.  
|
|
0.1958 0.006 (0.03%) |
12-13 15:59 |
|
Open: |
0.2 |
Pre close: |
0.19 |
Target:
|
0.26
|
|
High: |
0.2046 |
Low: |
0.1946 |
Resistance:
|
0.22
0.25
|
|
Volume: |
131,565 |
Market Cap: |
9M |
Support:
|
0.18
0.15
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.19
 |
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
0.20  |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
0.24 |
Stochastic Oscillator |
%K(14,3):
|
17.47 |
|
MA(250): |
0.33 |
%D(3): |
19.16 |
|
Average Volume(K) |
3-Month: |
26268
|
52-Week |
High:
|
0.65 |
|
10-Days: |
21372 |
Low: |
0.15 |
|
RSI |
RSI(14):
|
48.25 |
Change(%): |
-36.7 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-123.8 |
Shares Out. (M) |
48.19 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-68.2 |
Shares Float (M) |
44.34 |
|
EPS Est. Next Year |
-0.030 |
PEG Ratio |
0.00 |
% Held by Insiders |
9.80 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-57.8 |
% Held by Institutions |
8.00 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
448 |
|
Book Value (p.s.) |
1.350 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.15 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-8.98 |
P/S |
0.00 |
|
Operating Margin |
-6565.54 |
Levered Free Cash Flow
(M) |
-5.66 |
P/CF |
-1.05 |
|
|
|
|
|
|
